Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach

Sita Sirisha Madugula; Selvaraman Nagamani; Esther Jamir; Lipsa Priyadarsinee; G. Narahari Sastry

doi:10.1007/s11030-021-10296-2

ScienceGate Book Chapters

JOURNAL ARTICLE

Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach

Sita Sirisha Madugula Selvaraman Nagamani Esther Jamir Lipsa Priyadarsinee G. Narahari Sastry

Year: 2021 Journal: Molecular Diversity Vol: 26 (3)Pages: 1675-1695 Publisher: Springer Science+Business Media

DOI: 10.1007/s11030-021-10296-2

Get Full-Text PDF Get Analytical Report

Keywords:

Antimycobacterial Drug repositioning Druggability Drug In silico Mycobacterium tuberculosis Drug discovery Tuberculosis Pharmacology Virtual screening Computational biology Approved drug Medicine Drug development Chemistry Biology Bioinformatics

Metrics

Cited By

1.44

FWCI (Field Weighted Citation Impact)

Refs

0.83

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Computational Drug Discovery Methods

Physical Sciences → Computer Science → Computational Theory and Mathematics

Tuberculosis Research and Epidemiology

Health Sciences → Medicine → Infectious Diseases

Synthesis and biological activity

Physical Sciences → Chemistry → Organic Chemistry

Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach

Metrics

Citation History

Topics

Related Documents

Polypharmacology guided drug repositioning approach for SARS-CoV2

GES Polypharmacology Fingerprints: A Novel Approach for Drug Repositioning

Systematic Approach for Drug Repositioning of Anti-Epileptic Drugs

PATHOME-Drug: a subpathway-based polypharmacology drug-repositioning method

Network-based drug repositioning approach for tuberculosis